nach oben

International Urogynecology Journal

Erschienen in:

18.06.2020 | Original Article

Obstructive patterns in videourodynamic studies predict responses of female dysfunctional voiding treated with or without urethral botulinum toxin injection: a long-term follow-up study

verfasst von: Po-Ming Chow, Sheng-Mou Hsiao, Hann-Chorng Kuo

Erschienen in: International Urogynecology Journal | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

We report long-term changes in VUDS profiles of women with dysfunctional voiding and investigate potential predictors for treatment response.

Methods

Women with dysfunctional voiding and available VUDS data between November 1997 and June 2018 were enrolled for retrospective analysis. The patients were all treated with medication first. In refractory patients, urethral botulinum toxin was provided as an additional option. The primary outcome was the change of VUDS parameters between baseline and follow-up studies. The secondary outcomes were baseline parameters and clinical factors that were associated with the BOOI response (> 10 points of BOOI reduction).

Results

A total of 195 women with DV were included in this study. The mean age was 54.5 years old. Sixty patients received urethral botulinum toxin injection. For all patients, Pdet decreased from 47.2 to 36.8 cm H₂O (p < 0.0001), and BOOI decreased from 26.4 to 17.7 (p = 0.0001). Patients with urethral injection had significantly smaller Qmax, voided volume, and voiding efficiency (VE) and significantly larger PVR and BOOI at baseline, indicating a severer obstruction in this group. The overall BOOI response rate was 44% (85/195). A higher baseline BOOI was associated with the BOOI response in multivariate analysis.

Conclusions

In this long-term study of women with dysfunctional voiding, medical treatment with or without urethral botulinum toxin injection both resulted in reduction of Pdet and BOOI. A more prominent obstructive profile at baseline VUDS study was associated with a higher rate of BOOI response at follow-up study.

Nur mit Berechtigung zugänglich

Massey JA, Abrams PH. Obstructed voiding in the female. Br J Urol. 1988;61(1):36–9. https://doi.org/10.1111/j.1464-410x.1988.tb09158.x.CrossRefPubMed

Nitti VW, Tu LM, Gitlin J. Diagnosing bladder outlet obstruction in women. J Urol. 1999;161(5):1535–40.CrossRef

Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn. 2000;19(3):213–20.CrossRef

Choi YS, Kim JC, Lee KS, Seo JT, Kim HJ, Yoo TK, et al. Analysis of female voiding dysfunction: a prospective, multi-center study. Int Urol Nephrol. 2013;45(4):989–94. https://doi.org/10.1007/s11255-013-0475-2.CrossRefPubMed

Meier K, Padmanabhan P. Female bladder outlet obstruction: an update on diagnosis and management. Curr Opin Urol. 2016;26(4):334–41. https://doi.org/10.1097/MOU.0000000000000303.CrossRefPubMed

Kuo HC. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology. 2005;66(5):1005–9. https://doi.org/10.1016/j.urology.2005.05.047.CrossRefPubMed

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78. https://doi.org/10.1002/nau.10052.CrossRefPubMed

Gammie A, Kirschner-Hermanns R, Rademakers K. Evaluation of obstructed voiding in the female: how close are we to a definition? Curr Opin Urol. 2015;25(4):292–5. https://doi.org/10.1097/MOU.0000000000000182.CrossRefPubMed

King AB, Goldman HB. Bladder outlet obstruction in women: functional causes. Curr Urol Rep. 2014;15(9):436. https://doi.org/10.1007/s11934-014-0436-z.CrossRefPubMed

10.

Jiang YH, Liao CH, Kuo HC. Current and potential urological applications of botulinum toxin a. Nat Rev Urol. 2015;12(9):519–33. https://doi.org/10.1038/nrurol.2015.193.CrossRefPubMed

11.

Kim DK, Lee JY, Jung JH, Kim JH, Hah YS, Hong CH, et al. Alpha-1 adrenergic receptor blockers for the treatment of lower urinary tract symptoms in women: a systematic review and meta-analysis. Int Neurourol J. 2019;23(1):56–68. https://doi.org/10.5213/inj.1836188.094.CrossRefPubMedPubMedCentral

12.

Chen YC, Kuo HC. Clinical and video urodynamic characteristics of adult women with dysfunctional voiding. J Formosan Med Assoc = Taiwan yi zhi. 2014;113(3):161–5. https://doi.org/10.1016/j.jfma.2012.04.008.CrossRefPubMed

13.

Morin F, Akhavizadegan H, Kavanagh A, Moore K. Dysfunctional voiding: challenges of disease transition from childhood to adulthood. Can Urol Assoc J = Journal de l'Association des urologues du Canada. 2018;12(4 Suppl 1):S42–7. https://doi.org/10.5489/cuaj.5230.CrossRefPubMed

14.

Jiang YH, Wang CC, Kuo HC. OnabotulinumtoxinA urethral sphincter injection as treatment for non-neurogenic voiding dysfunction—a randomized, double-blind, placebo-controlled study. Sci Rep. 2016;6:38905. https://doi.org/10.1038/srep38905.CrossRefPubMedPubMedCentral

15.

Lemack GE, Zimmern PE. Pressure flow analysis may aid in identifying women with outflow obstruction. J Urol. 2000;163(6):1823–8.CrossRef

16.

Haylen BT, Ashby D, Sutherst JR, Frazer MI, West CR. Maximum and average urine flow rates in normal male and female populations—the Liverpool nomograms. Br J Urol. 1989;64(1):30–8. https://doi.org/10.1111/j.1464-410x.1989.tb05518.x.CrossRefPubMed

17.

Groutz A, Blaivas JG. Non-neurogenic female voiding dysfunction. Curr Opin Urol. 2002;12(4):311–6.CrossRef

18.

Peng CH, Chen SF, Kuo HC. Videourodynamic analysis of the urethral sphincter overactivity and the poor relaxing pelvic floor muscles in women with voiding dysfunction. Neurourol Urodyn. 2017;36(8):2169–75. https://doi.org/10.1002/nau.23263.CrossRefPubMed

19.

Wada N, Kita M, Hashizume K, Matsumoto S, Kakizaki H. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: prospective pressure-flow study. Neurourol Urodyn. 2013;32(8):1123–7. https://doi.org/10.1002/nau.22349.CrossRefPubMed

20.

Rigatti L, Naspro R, Salonia A, Centemero A, Ghezzi M, Guazzoni G, et al. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up? Urology. 2006;67(6):1193–8. https://doi.org/10.1016/j.urology.2005.12.036.CrossRefPubMed

21.

Gravina GL, Costa AM, Ronchi P, Galatioto GP, Luana G, Vicentini C. Bladder outlet obstruction index and maximal flow rate during urodynamic study as powerful predictors for the detection of urodynamic obstruction in women. Neurourol Urodyn. 2007;26(2):247–53. https://doi.org/10.1002/nau.20375.CrossRefPubMed

22.

Pummangura N, Kochakarn W. Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women. Asian J Surg. 2007;30(2):131–7. https://doi.org/10.1016/S1015-9584(09)60146-9.CrossRefPubMed

23.

Kim SO, Hwang EC, Oh KJ, Kwon D, Park K, Ryu SB. Efficacy and safety of combined therapy with tamsulosin and tolterodine in female patients with a maximal flow rate less than 12 ml/s. Int Urogynecol J. 2011;22(10):1287–91. https://doi.org/10.1007/s00192-011-1453-9.CrossRefPubMed

24.

Pischedda A, Pirozzi Farina F, Madonia M, Cimino S, Morgia G. Use of alpha1-blockers in female functional bladder neck obstruction. Urol Int. 2005;74(3):256–61. https://doi.org/10.1159/000083559.CrossRefPubMed

25.

Low BY, Liong ML, Yuen KH, Chee C, Leong WS, Chong WL, et al. Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial. J Urol. 2008;179(4):1461–9. https://doi.org/10.1016/j.juro.2007.11.060.CrossRefPubMed

26.

Lee YS, Lee KS, Choo MS, Kim JC, Lee JG, Seo JT, et al. Efficacy of an alpha-blocker for the treatment of nonneurogenic voiding dysfunction in women: an 8-week, randomized, double-blind, placebo-controlled trial. Int Neurourol J. 2018;22(1):30–40. https://doi.org/10.5213/inj.1834904.452.CrossRefPubMedPubMedCentral

27.

Xu D, Qu C, Meng H, Ren J, Zhu Y, Min Z, et al. Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial. BJU Int. 2007;100(3):588–92. https://doi.org/10.1111/j.1464-410X.2007.06987.x.CrossRefPubMed

28.

Chen CH, Hsiao SM, Chang TC, Wu WY, Lin HH. Clinical and urodynamic effects of baclofen in women with functional bladder outlet obstruction: preliminary report. J Obstet Gynaecol Res. 2016;42(5):560–5. https://doi.org/10.1111/jog.12932.CrossRefPubMed

29.

Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum a toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol. 1988;139(5):919–22. https://doi.org/10.1016/s0022-5347(17)42717-0.CrossRefPubMed

30.

Steinhardt GF, Naseer S, Cruz OA. Botulinum toxin: novel treatment for dramatic urethral dilatation associated with dysfunctional voiding. J Urol. 1997;158(1):190–1. https://doi.org/10.1097/00005392-199707000-00067.CrossRefPubMed

31.

Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001;165(4):1107–10.CrossRef

32.

Kuo HC. Botulinum a toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol. 2003;170(5):1908–12. https://doi.org/10.1097/01.ju.0000091281.50081.f0.CrossRefPubMed

Titel: Obstructive patterns in videourodynamic studies predict responses of female dysfunctional voiding treated with or without urethral botulinum toxin injection: a long-term follow-up study
verfasst von: Po-Ming Chow
Sheng-Mou Hsiao
Hann-Chorng Kuo
Publikationsdatum: 18.06.2020
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal / Ausgabe 12/2020
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-020-04333-1

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Obstructive patterns in videourodynamic studies predict responses of female dysfunctional voiding treated with or without urethral botulinum toxin injection: a long-term follow-up study

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

The responsiveness and minimally important difference for the Accidental Bowel Leakage Evaluation questionnaire

Racism and urogynecology: what is the connection?

Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years?

Search for the G spot: microvessel and nerve mapping of the paraurethral anterior vaginal wall

Women living with a midurethral sling in their 80s: long-term outcomes

Translation of the ICIQ-bladder diary and its validation among Chinese females with lower urinary tract symptoms

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie